Financhill
Back

Verona Pharma PLC Vs. Adaptimmune Therapeutics PLC Industry Stock Comparison

Buy
51

VRNA
Verona Pharma PLC

Last Price:
38.47
Seasonality Move:
15.78%
Sell
30

ADAP
Adaptimmune Therapeutics PLC

Last Price:
0.83
Seasonality Move:
40.93%
Buy
51
Verona Pharma PLC (VRNA) is a Buy

Is Verona Pharma PLC a Buy, Sell or Hold?

  • The current Verona Pharma PLC [VRNA] share price is $38.39. The Score for VRNA is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
  • VRNA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Adaptimmune Therapeutics PLC (ADAP) is a Sell

Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?

  • The current Adaptimmune Therapeutics PLC [ADAP] share price is $0.83. The Score for ADAP is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • ADAP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VRNA Stock Price Chart

What is Verona Pharma PLC's stock price today?

  • The Verona Pharma PLC share price today is $38.39
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VRNA is experiencing slight selling pressure.

ADAP Stock Price Chart

What is Adaptimmune Therapeutics PLC's stock price today?

  • The Adaptimmune Therapeutics PLC share price today is $0.83
    The current trend is relatively stagnant and ADAP is experiencing buying pressure, which is a positive indicator for future bullish movement.

VRNA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.67 Buy
Relative Strength Index (14 RSI): 77.19 Buy
Chaikin Money Flow: -316678 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (31.23 - 35.69) Buy
Bollinger Bands (100): (19.46 - 32.14) Buy

ADAP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.05 Sell
Relative Strength Index (14 RSI): 48.33 Sell
Chaikin Money Flow: 444283 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.76 - 0.9) Sell
Bollinger Bands (100): (0.87 - 1.21) Sell

VRNA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.03 Buy
20-day SMA: 34.2 Buy
50-day SMA: 30.9 Buy
200-day SMA: 20.72 Buy
8-day EMA: 35.79 Buy
20-day EMA: 34.16 Buy
50-day EMA: 31.06 Buy
200-day EMA: 23.23 Buy

ADAP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.76 Buy
20-day SMA: 0.81 Buy
50-day SMA: 0.96 Sell
200-day SMA: 1.13 Sell
8-day EMA: 0.78 Buy
20-day EMA: 0.82 Buy
50-day EMA: 0.91 Sell
200-day EMA: 1.03 Sell

Verona Pharma PLC Earnings Growth & VRNA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.32 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.73 per share, and an increase next year of $1.25 per share.

Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and a decrease next year of $0.34 per share.

Verona Pharma PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Adaptimmune Therapeutics PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):